<DOC>
	<DOC>NCT01678872</DOC>
	<brief_summary>The purpose of this study is to examine the long term safety of an experimental gene transfer agent, RetinoStat®, designed to treat neovascular age-related macular degeneration.</brief_summary>
	<brief_title>A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Must have received a subretinal injection of RetinoStat Must have been enrolled in Protocol RS1/001/10 Did not receive RetinoStat® as part of the RS1/001/10 protocol</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>